Clinical Trials Logo

Tobacco Use Disorder clinical trials

View clinical trials related to Tobacco Use Disorder.

Filter by:

NCT ID: NCT03720899 Completed - Smoking Cessation Clinical Trials

Comparing NicoBloc to Nicotine Lozenges

Start date: March 21, 2019
Phase: Phase 2/Phase 3
Study type: Interventional

To examine the feasibility, acceptability, and preliminary impact of using NicoBloc compared to nicotine lozenges

NCT ID: NCT03719391 Completed - Nicotine Dependence Clinical Trials

United States Pre-Market Tobacco Application Pharmacokinetics

US-PMTA-PK
Start date: October 19, 2018
Phase: N/A
Study type: Interventional

A Randomized, Open-Label, Cross-Over Study to Assess Nicotine Uptake and Subjective Measures with Use of JUUL 5% Electronic Nicotine Delivery Systems (ENDS) Compared to Usual Brand Combustible Cigarettes, a Comparator E-Cigarette, and Nicotine Gum in Healthy Adult Smokers

NCT ID: NCT03713424 Recruiting - Clinical trials for Tobacco Use Disorder

An fMRI Study of the Effects of Clavulanic Acid on Drug Addiction

Start date: March 26, 2019
Phase: Phase 2
Study type: Interventional

This research study is looking into the effects of clavulanic on smoking behavior in adult cigarette smokers. The primary study hypothesis is that, compared to placebo, clavulanic acid will reduce smoking over the course of the study.

NCT ID: NCT03712098 Completed - Smoking Cessation Clinical Trials

Daily Liraglutide for Nicotine Dependence

DAL
Start date: November 29, 2018
Phase: Phase 2
Study type: Interventional

This clinical research trial examines the effects of the GLP-1 receptor agonist liraglutide on smoking behavior, food intake, and weight gain. In this double-blind, placebo-controlled, parallel arm pilot study, overweight and obese smokers (N=40; 20 female and 20 male) will be randomized to 32 weeks of liraglutide or placebo and undergo 8 sessions of smoking cessation behavioral counseling. Outcomes are smoking abstinence and weight change.

NCT ID: NCT03707600 Withdrawn - Nicotine Dependence Clinical Trials

State and Trait Mediated Response to TMS in Substance Use Disorder

Start date: September 27, 2018
Phase: N/A
Study type: Interventional

OBJECTIVES: The current protocol seeks to develop brain-based intermediate phenotypes of response to transcranial magnetic stimulation (TMS) in chronic substance use disorder (SUD). To date the field has relied on subjective reports, behavioral performance, and long-term clinical outcomes as primary measures of TMS efficacy. While certainly ecologically valid, these observable behaviors lack the sensitivity necessary to fully quantify the effects (or lack thereof) across both individual participants and TMS intervention protocols. This proposed within-subjects design seeks to leverage differences in metaplasticity that is, the context in which stimulation occurs-by studying the response to stimulation in both sated and abstinent states. It is predicted these state manipulations will potentiate response to TMS. When a disruptive allostatic load like chronic nicotine exposure or acute abstinence is placed on the brain, the underlying network becomes less stable and thus more susceptible to TMS intervention. For SUD in general and tobacco use disorder (TUD) in particular, this state dependence of TMS response is a potentially valuable tool to improve a given intervention s clinical efficacy. STUDY POPULATION: Physically and psychiatrically healthy smokers will be recruited. A comparison group of non-smokers will be concurrently enrolled. We estimate we will require n=51/group of completers to have sufficient power to develop the intermediate phenotypes of TMS. DESIGN: The protocol is a two group, between/within subject, fully counterbalanced design. The between-subjects factor is GROUP (smoker/non-smoker) and the within-subjects factor for each GROUP is TMS CONDITION (active/sham). Additionally, and for the smoker group, nicotine STATE (sated/abstinent) is a nested within-subjects factor. Each group will receive single sessions of active and sham intermittent theta burst stimulation to left dorsal lateral prefrontal cortex, followed immediately by an MRI scan to characterize the acute neurobiological response to stimulation. Smokers will repeat these procedures both during smoking satiety and following an ~48-hour period nicotine abstinence. OUTCOMES PARAMETERS: In addition to subjective and behavioral task performance changes associated with TMS intervention, changes in MRI BOLD signal will be used to characterize the neurobiological response to TMS intervention across groups and states. Taken together, the development of brain-based markers of TMS response may thus improve both our mechanistic understanding of the causal dysfunctions of TUD as well as the potential efficacy of these interventions longer term to address the relevant clinical characteristics of the disease and ultimately improve treatment outcomes.

NCT ID: NCT03700112 Completed - Nicotine Dependence Clinical Trials

Clinical Study Comparing 7 ENDS Products and 1 Combustible Cigarette Using 2 Delivery Methods.

Start date: December 4, 2018
Phase: N/A
Study type: Interventional

A Randomized Study Comparing Nicotine Pharmacokinetics of Seven Electronic Cigarette Products and One Traditional Cigarette Across Two Delivery (10 puff and ad- libitum) Conditions, in Healthy Adult Smokers

NCT ID: NCT03694327 Completed - Smoking Cessation Clinical Trials

Innovative Digital Therapeutic for Smoking Cessation

Start date: October 24, 2018
Phase: N/A
Study type: Interventional

This study is comparing the efficacy of two smoking cessation apps.

NCT ID: NCT03691805 Completed - Clinical trials for Tobacco Use Disorder

Transcranial Direct Current Stimulation - Tobacco Use Disorder

Start date: October 15, 2018
Phase: N/A
Study type: Interventional

This study aims to detect how transcranial direct current stimulation (tDCS) affects smokers' inhibitory control, craving and consumption of tobacco goods.

NCT ID: NCT03635333 Completed - Clinical trials for Nicotine Use Disorder

Effects of E-Cigarette Flavors on Adults TCORS 2.0

Start date: March 15, 2019
Phase: Phase 1
Study type: Interventional

This study looks at the effects of flavors when administered with nicotine in e-cigarettes in younger and older adult cigarette smokers.

NCT ID: NCT03634839 Completed - Clinical trials for Nicotine Use Disorder

Effects of E-cigarette Flavors on Youth TCORS 2.0

Start date: November 7, 2022
Phase: Phase 1
Study type: Interventional

This study is an examination of the influence of sweet and cooling flavors on the appeal and abuse potential of nicotine-containing e-cigarettes among susceptible youth.